FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers
The FDA Last week permitted the Marketing of Dermapace System, first shock device to treat Diabetic Foot ulcers.
“Diabetes is the leading cause of lower limb amputations,” said Binita Ashar, M.D., director of the division of surgical devices in FDA’s Center for Devices and Radiological Health. “The FDA is dedicated to making technologies available that can help improve the quality of life for those with chronic diseases. Additional options for successfully treating and healing ulcer wounds may help prevent lower limb amputations.”